Magnetic resonance imaging. Liver-specific contrast agents.
MR imaging with new liver-specific contrast agents will probably be the imaging modality used in the future to detect focal liver lesions. The detection of HCC will probably be improved by using specific hepatobiliary agents, but the exact technique remains to be determined. New liver-specific contrast can differentiate some benign lesions from malignant ones and can assist in making a final diagnosis. In certain circumstances, liver-specific contrast agents can be used to evaluate hepatic vessels, the biliary tract, and hepatic function. New applications are also expected.